Discover how PMEPA1 and NEDD4-1 partnership controls androgen receptor degradation in prostate cancer through molecular mechanisms and therapeutic implications.
Discover how prostate cancer disables the PMEPA1-NEDD4 molecular brake system that regulates androgen receptor stability, leading to treatment resistance.